Pricing Log in Create free account

HeartSciences Inc. (HSCS) vs SINTX TECHNOLOGIES, INC. (SINT)

HeartSciences Inc. and SINTX TECHNOLOGIES, INC. are both Medical Devices companies. HeartSciences Inc. is the larger, with a market value of $15.4M against $13.4M — 1.2× the size. HeartSciences Inc. grew revenue faster over the last twelve months: 131.9% against −28.5%. SINTX TECHNOLOGIES, INC. has the higher net margin (−1,423.0% vs −48,621.8%) and the lower return on invested capital (−548.1% vs 0.00%). Across the 17 metrics below, SINTX TECHNOLOGIES, INC. leads on 10 and HeartSciences Inc. on 7.

Valuation

Metric HSCS SINT Medical Devices median
P/E n/m n/m 23.22
P/S 525.12 6.34 2.34
P/B n/m 1.75 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 555.53 3.73 2.24
Earnings yield (106.62%) (301.45%) (10.09%)
Free cash flow yield (64.22%) (123.09%) (8.47%)

Profitability

Metric HSCS SINT Medical Devices median
Gross margin 18.01% 52.86% 56.01%
Operating margin (44,918.48%) (884.81%) (15.03%)
Net margin (48,621.80%) (1,423.01%) (20.40%)
Free cash flow margin (33,725.12%) (777.14%) (7.24%)
Return on equity (1,854.69%) (429.26%) (15.32%)
Return on assets (201.67%) (192.88%) (19.72%)
Return on invested capital 0.00% (548.06%) (10.33%)

Growth

Metric HSCS SINT Medical Devices median
Revenue growth (TTM) 131.87% (28.53%) 8.80%
EPS growth (last fiscal year) 62.74% 59.45% 29.03%
Revenue growth, 5-year CAGR (30.01%) 11.38% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HSCS SINT Medical Devices median
Debt to equity 0.00 0.02 0.07
Current ratio 0.14 2.36 2.50
Net debt to EBITDA 0.21 0.41 0.49

Dividend

Metric HSCS SINT Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric HSCS SINT Medical Devices median
Market cap 15.41m 13.38m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack